We are live on ! Find out more
TCM

Tributary Capital Management Portfolio holdings

AUM $1.22B
1-Year Est. Return 44.12%
This Fund
S&P 500
This Quarter Est. Return
+12.18%
1 Year Est. Return
+44.12%
3 Year Est. Return
+82.34%
5 Year Est. Return
+109.28%
10 Year Est. Return
+466.43%
AUM
$1.32B
AUM Growth
+$30.1M
Cap. Flow
-$106M
Cap. Flow %
-8.04%
Top 10 Hldgs %
20.06%
Holding
237
New
7
Increased
42
Reduced
173
Closed
14

Top Sells

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$16.9M
2
OMCL icon
Omnicell
OMCL
+$13.3M
3
BOOT icon
Boot Barn
BOOT
+$11M
4
ONTO icon
Onto Innovation
ONTO
+$8.96M
5
AMBA icon
Ambarella
AMBA
+$7.41M

Sector Composition

Rank Sector Weight
1 Technology 17.71%
2 Industrials 16.46%
3 Financials 14.57%
4 Healthcare 12.82%
5 Consumer Discretionary 12.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JJSF icon
51
J&J Snack Foods
JJSF
$1.72B
$12M 0.91%
75,913
-4,695
-6% -$706K
AMBA icon
52
Ambarella
AMBA
$3.68B
$11.6M 0.87%
56,969
-39,959
-41% -$7.41M
OMCL icon
53
Omnicell
OMCL
$1.64B
$11.5M 0.87%
63,708
-76,646
-55% -$13.3M
UMBF icon
54
UMB Financial
UMBF
$11B
$11.4M 0.86%
107,382
-6,280
-6% -$648K
CACI icon
55
CACI
CACI
$13.9B
$11.2M 0.85%
41,606
-2,404
-5% -$658K
MBWM icon
56
Mercantile Bank Corp
MBWM
$1.06B
$11.1M 0.84%
317,920
-19,694
-6% -$686K
SF
57
Stifel
SF
$12.6B
$10.8M 0.82%
231,110
-13,054
-5% -$634K
PCRX icon
58
Pacira BioSciences
PCRX
$1.02B
$10.8M 0.81%
179,207
-11,069
-6% -$610K
MEDP icon
59
Medpace
MEDP
$16.3B
$10.8M 0.81%
49,451
-80,823
-62% -$16.9M
GTY
60
Getty Realty Corp
GTY
$2.06B
$10.7M 0.81%
334,079
-20,697
-6% -$655K
SPSC icon
61
SPS Commerce
SPSC
$2.59B
$9.77M 0.74%
68,657
-4,255
-6% -$638K
SUPN icon
62
Supernus Pharmaceuticals
SUPN
$2.72B
$9.35M 0.71%
320,742
-19,875
-6% -$603K
CASS icon
63
Cass Information Systems
CASS
$742M
$8.82M 0.67%
224,453
-13,819
-6% -$586K
UTL icon
64
Unitil
UTL
$981M
$8.63M 0.65%
187,670
-12,193
-6% -$529K
AAPL icon
65
Apple
AAPL
$4.56T
$4.44M 0.34%
24,997
-835
-3% -$132K
MSFT icon
66
Microsoft
MSFT
$3.71T
$4.03M 0.3%
11,975
-400
-3% -$130K
EPAM icon
67
EPAM Systems
EPAM
$4.86B
$3.68M 0.28%
5,500
-800
-13% -$515K
MCHP icon
68
Microchip Technology
MCHP
$40.4B
$3.42M 0.26%
39,319
-4,367
-10% -$353K
FTNT icon
69
Fortinet
FTNT
$117B
$3.16M 0.24%
44,000
-4,500
-9% -$296K
IDXX icon
70
Idexx Laboratories
IDXX
$46.5B
$3.16M 0.24%
4,800
-800
-14% -$502K
SNPS icon
71
Synopsys
SNPS
$77.7B
$2.98M 0.23%
8,100
-900
-10% -$304K
HZNP
72
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.96M 0.22%
27,500
-2,150
-7% -$235K
PANW icon
73
Palo Alto Networks
PANW
$293B
$2.95M 0.22%
31,800
-7,800
-20% -$675K
CTAS icon
74
Cintas
CTAS
$80.9B
$2.92M 0.22%
26,400
-2,800
-10% -$302K
ODFL icon
75
Old Dominion Freight Line
ODFL
$44B
$2.92M 0.22%
16,300
-4,500
-22% -$759K

Similar funds

Tributary Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Tributary Capital Management held 237 positions worth $1.32B, up 2.3% from $1.29B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Tributary Capital Management withdrew a net $106M in Q4 2021, closing 14 positions and reducing 173 holdings. Its most notable exit was DraftKings, an estimated $1.32M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

Against the trend, Tributary Capital Management opened a new position in Plug Power worth $1.95M.

  • Tributary Capital Management's largest Q4 2021 buy was Plug Power: 69,000 shares worth $1.95M.
  • Tributary Capital Management added most to LHC Group LLC in Q4 2021, an estimated $16M increase.
  • Tributary Capital Management's biggest Q4 2021 reduction was Medpace, cutting an estimated $16.9M.
  • Tributary Capital Management fully exited DraftKings in Q4 2021, selling an estimated $1.32M.
  • Tributary Capital Management's ten largest holdings make up 20% of its $1.32B portfolio in Q4 2021.
  • Tributary Capital Management opened 7 new positions and closed 14 in Q4 2021.
  • Tributary Capital Management's portfolio value rose 2.3% quarter-over-quarter to $1.32B.

Based on Tributary Capital Management's 13F filing for Q4 2021, filed 6 Jan 2022.